First new treatment for asthma attacks in 50 years can reduce need for hospitalisation by 30 percent
Benralizamab is a monoclonal antibody which targets specific white blood cells, called eosinophils, to reduce lung ...
An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets.
The U.S. pharmaceutical industry seeks to alter Medicare drug price negotiation laws under Trump's return. China approves ...
Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid ...
We are grateful to our colleagues for their interest and thoughtful comments on our Seminar about systemic lupus erythematosus (SLE).1 We appreciate the remarks from Qihe Xu, and Thomas Pabst and ...
A new study, supported by AstraZeneca, has shown that a single dose of benralizumab significantly reduces treatment failure ...
Pfizer Inc. (NYSE: PFE), and AstraZeneca plc (NASDAQ: AZN) may have faded from the spotlight since the peak of the COVID-19 ...
Trump’s tariff plans could hit UK exports like Land Rovers, pharmaceuticals, and machinery, leaving key British industries ...
AstraZeneca's blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an ...
China approved AstraZeneca Plc’s blockbuster breast cancer treatment for reimbursement by state-run medical insurance, a move ...
AstraZeneca's Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that ...
Truqap combination showed a statistically and clinically meaningful improvement in radiographic progression-free survival for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback